Principal Financial Group Inc. Purchases 6,607 Shares of Addus HomeCare Corporation $ADUS

Principal Financial Group Inc. boosted its position in Addus HomeCare Corporation (NASDAQ:ADUS) by 1.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 442,362 shares of the company’s stock after purchasing an additional 6,607 shares during the quarter. Principal Financial Group Inc. owned about 2.39% of Addus HomeCare worth $47,505,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in ADUS. Capital Research Global Investors boosted its stake in Addus HomeCare by 9.0% in the 3rd quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after purchasing an additional 99,262 shares during the period. 8 Knots Management LLC bought a new stake in Addus HomeCare in the 3rd quarter valued at $6,075,000. Peregrine Capital Management LLC boosted its stake in Addus HomeCare by 25,272.2% in the 3rd quarter. Peregrine Capital Management LLC now owns 45,670 shares of the company’s stock valued at $5,389,000 after purchasing an additional 45,490 shares during the period. Adage Capital Partners GP L.L.C. bought a new stake in Addus HomeCare in the 2nd quarter valued at $4,838,000. Finally, Vanguard Group Inc. boosted its stake in Addus HomeCare by 2.9% in the 3rd quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock valued at $153,163,000 after purchasing an additional 36,674 shares during the period. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $99.57 on Friday. The stock has a fifty day moving average price of $97.85 and a 200-day moving average price of $107.39. The company has a market cap of $1.86 billion, a price-to-earnings ratio of 18.40, a PEG ratio of 1.34 and a beta of 0.92. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.80 and a current ratio of 1.83. Addus HomeCare Corporation has a fifty-two week low of $90.89 and a fifty-two week high of $124.43.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter in the previous year, the firm earned $1.42 EPS. Addus HomeCare’s revenue was up 7.7% on a year-over-year basis. As a group, equities analysts anticipate that Addus HomeCare Corporation will post 6.21 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, CEO R Dirk Allison sold 4,988 shares of the business’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $533,616.24. Following the completion of the transaction, the chief executive officer owned 185,514 shares of the company’s stock, valued at approximately $19,846,287.72. The trade was a 2.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Brian Poff sold 2,041 shares of the business’s stock in a transaction on Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total value of $218,346.18. Following the transaction, the executive vice president directly owned 64,512 shares of the company’s stock, valued at $6,901,493.76. This trade represents a 3.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 16,788 shares of company stock worth $1,785,633 in the last three months. Insiders own 4.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Stephens cut their target price on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research report on Wednesday, February 25th. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. Citizens Jmp cut their target price on Addus HomeCare from $150.00 to $142.00 and set a “market outperform” rating for the company in a research report on Wednesday. Finally, Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $132.33.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.